Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Altimmune (ALT) Other Operating Expenses (2016 - 2023)

Historic Other Operating Expenses for Altimmune (ALT) over the last 10 years, with Q4 2023 value amounting to $12.4 million.

  • Altimmune's Other Operating Expenses changed N/A to $12.4 million in Q4 2023 from the same period last year, while for Sep 2024 it was $12.4 million, marking a year-over-year change of. This contributed to the annual value of $12.4 million for FY2023, which is N/A changed from last year.
  • Latest data reveals that Altimmune reported Other Operating Expenses of $12.4 million as of Q4 2023.
  • In the past 5 years, Altimmune's Other Operating Expenses registered a high of $12.4 million during Q4 2023, and its lowest value of $1.0 million during Q3 2019.
  • Its 3-year average for Other Operating Expenses is $6.2 million, with a median of $5.7 million in 2021.
  • Data for Altimmune's Other Operating Expenses shows a peak YoY increase of 10301.51% (in 2019) and a maximum YoY decrease of 10301.51% (in 2019) over the last 5 years.
  • Quarter analysis of 3 years shows Altimmune's Other Operating Expenses stood at $1.0 million in 2019, then surged by 230.0% to $3.3 million in 2021, then skyrocketed by 276.33% to $12.4 million in 2023.
  • Its Other Operating Expenses stands at $12.4 million for Q4 2023, versus $3.3 million for Q4 2021 and $8.1 million for Q2 2021.